IQVIA Holdings Inc. (NYSE:IQV) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 6, 2025 IQVIA Holdings Inc. beats earnings expectations. Reported EPS is $3.12, expectations were $3.11. Operator: Ladies and gentlemen, thank you for standing by.
IQVIA (IQV) Q4 Earnings Report Preview: What To Look For
Clinical research company IQVIA (NYSE: IQV) will be announcing earnings results tomorrow before market hours. Here’s what to look for.
Iqvia reports Q4 EPS $3.12, consensus $3.11
Adjusted EBITDA of $996 M for the fourth quarter, $3,684 Mfor the full year;R&D Solutions quarterly bookings of over $2.5 billion, representing a book-to-bill ratio of 1.20x ;R&D Solutions contracted backlog of $31.
IQVIA: Q4 Earnings Snapshot
The average estimate of 10 analysts surveyed by Zacks Investment Research was for earnings of $3.10 per share. The clinical testing company posted revenue of $3.96 billion in the period, also surpassing Street forecasts.
IQVIA Holdings: Strong Earnings Amid Challenges
IQVIA Holdings (($IQV)) has held its Q4 earnings call. Read on for the main highlights of the call. IQVIA Holdings’ recent earnings call reflected
IQVIA Earnings & Revenues Surpass Estimates in Q4, Increase Y/Y
IQVIA Holdings Analytics Inc. IQV has reported impressive fourth-quarter 2024 results, wherein earnings and revenues beat the Zacks Consensus Estimate. See Zacks Earnings Calendar to stay ahead of market-making news.
StockStory.org on MSN3h
Medpace (MEDP) To Report Earnings Tomorrow: Here Is What To Expect
Clinical research company Medpace Holdings (NASDAQ:MEDP) will be announcing earnings results tomorrow after market hours.
IQVIA Holdings Inc. (NYSE:IQV) Shares Sold by abrdn plc
IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% in the 4th quarter, according to the company in its most recent ...
IQVIA Holdings Inc. stock outperforms competitors on strong trading day
Shares of IQVIA Holdings Inc. IQV rallied 2.20% to $209.96 Thursday, on what proved to be an all-around mixed trading session ...
IQVIA Delivers Solid Q4 Growth Despite 'Choppy' Market Conditions
IQVIA reaffirms its 2025 outlook, projecting up to $16.13 billion in revenue and EPS of $11.70-$12.10. Strong TAS growth and ...
DAVENPORT & Co LLC Trims Stake in IQVIA Holdings Inc. (NYSE:IQV)
DAVENPORT & Co LLC lowered its position in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 88.4% during the 4th quarter, ...
Iqvia price target raised to $260 from $250 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Iqvia (IQV) to $260 from $250 and keeps a Buy rating on the shares following the “solid” Q4 ...
IQVIA named to the Fortune® World’s Most Admired Companies™ list, ranked No. 1 in its sector for fourth consecutive year
IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence, ...
Reuters3d
IQVIA beats quarterly results estimates on analytics services demand
Feb 6 (Reuters) - Contract research firm IQVIA Holdings (IQV.N), opens new tab beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare ...
Iqvia price target raised to $220 from $210 at Baird
Baird raised the firm’s price target on Iqvia (IQV) to $220 from $210 and keeps a Neutral rating on the shares. The firm updated its model ...
IQVIA sees 2025 revenue growth of 4%-7% amid strong demand recovery
Q4 2024 Management View CEO Ari Bousbib highlighted that IQVIA achieved solid revenue growth of 5.5% at constant currency for the full year, excluding COVID-related revenues. Adjusted diluted EPS ...